✦ LIBER ✦

Dual Protein Farnesyltransferase−Geranylgeranyltransferase-I Inhibitors as Potential Cancer Chemotherapeutic Agents

✍ Scribed by deSolms, S. Jane; Ciccarone, Terrence M.; MacTough, Suzanne C.; Shaw, Anthony W.; Buser, Carolyn A.; Ellis-Hutchings, Michelle; Fernandes, Christine; Hamilton, Kelly A.; Huber, Hans E.; Kohl, Nancy E.; Lobell, Robert B.; Robinson, Ronald G.; Tsou, Nancy N.; Walsh, Eileen S.; Graham, Samuel L.; Beese, Lorena S.; Taylor, Jeffrey S.

Book ID: 121278458
Publisher: American Chemical Society
Year: 2003
Tongue: English
Weight: 214 KB
Volume: 46
Category: Article
ISSN: 0022-2623
DOI: 10.1021/jm020587n

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Macrocyclic Piperazinones as Potent Dual

Macrocyclic Piperazinones as Potent Dual Inhibitors of Farnesyltransferase and Geranylgeranyltransferase-I.

✍ Christopher J. Dinsmore; et al. et al. 📂 Article 📅 2004 🏛 John Wiley and Sons ⚖ 115 KB

THE POTENTIAL OF FARNESYLTRANSFERASE INH

THE POTENTIAL OF FARNESYLTRANSFERASE INHIBITORS AS CANCER CHEMOTHERAPEUTICS 1

✍ Gibbs, Jackson B.; Oliff, Allen 📂 Article 📅 1997 🏛 Annual Reviews 🌐 English ⚖ 176 KB

ChemInform Abstract: Aryloxy Substituted

ChemInform Abstract: Aryloxy Substituted N-Arylpiperazinones as Dual Inhibitors of Farnesyltransferase and Geranylgeranyltransferase-I.

✍ Jeffrey M. Bergman; et al. et al. 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 31 KB

Development of inhibitors of protein far

Development of inhibitors of protein farnesylation as potential chemotherapeutic agents

✍ Nancy E. Kohl; Michael W. Conner; Jackson B. Gibbs; Samuel L. Graham; George D. 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 565 KB

Protein prenylation, adding either the 15-carbon isoprenoid farnesyl or the 20-carbon isoprenoid geranylgeranyl to cysteine residuek) at or near the C-termini of proteins, is a recently identified post-translational modification that localizes some proteins to a membrane compartment. One of the most

Gliotoxin is a dual inhibitor of farnesy

Gliotoxin is a dual inhibitor of farnesyltransferase and geranylgeranyltransferase I with antitumor activity against breast cancer in vivo

✍ D. M. Vigushin; N. Mirsaidi; G. Brooke; C. Sun; P. Pace; L. Inman; C. J. Moody; 📂 Article 📅 2004 🏛 Springer US 🌐 English ⚖ 241 KB

[ACS Symposium Series] Anticancer Agents

[ACS Symposium Series] Anticancer Agents Volume 796 (Frontiers in Cancer Chemotherapy) || Farnesyltransferase Inhibitors as Potential Anticancer Agents

✍ Ojima, Iwao; Vite, Gregory D.; Altmann, Karl-Heinz 📂 Article 📅 2001 🏛 American Chemical Society ⚖ 811 KB